Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate
Generic / Active Ingredient
32 Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate brands in Bangladesh
Compare prices across every brand of Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate and pick the most affordable option.
| Brand | Strength | Form | Manufacturer | Price |
|---|---|---|---|---|
| Algicar Plus | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Techno Drugs Ltd. | ৳ 250.00 |
| Algicid DX | (500 mg+213 mg+325 mg)/10 ml | Oral Suspension | Incepta Pharmaceuticals Ltd. | ৳ 300.00 |
| Algicid Plus | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Incepta Pharmaceuticals Ltd. | ৳ 250.00 |
| Algisum Max | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Opsonin Pharma Ltd. | ৳ 250.00 |
| Ariscon | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Aristopharma Ltd. | ৳ 250.00 |
| Asynta Max | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Square Pharmaceuticals Ltd. | ৳ 250.00 |
| Gascon | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Pacific Pharmaceuticals Ltd. | ৳ 250.00 |
| Gastrocon-DA | (500 mg+213 mg+325 mg)/10 ml | Oral Suspension | UniMed UniHealth | ৳ 250.00 |
| Gastrocon-R | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | UniMed UniHealth | ৳ 250.00 |
| Gavicid | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Sharif Pharmaceuticals Ltd. | ৳ 250.00 |
| Gavicool | (500 mg+213 mg+325 mg)/10 ml | Oral Suspension | Pharmasia Limited | ৳ 15.00 |
| Gaviflux | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Beacon Pharmaceuticals Ltd. | ৳ 250.00 |
| Gavigin | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Virgo Pharmaceuticals Ltd. | ৳ 250.00 |
| Gavilac | (500 mg+213 mg+325 mg)/10 ml | Oral Suspension | ACI Limited | ৳ 250.00 |
| Gavimax | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Innovative Pharma (Albion) | ৳ 250.00 |
| Gavinate | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Labaid Pharma Ltd. | ৳ 250.00,100 |
| Gavinor | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Drug International Ltd. | ৳ 250.00 |
| Gavipex | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Apex Pharmaceuticals Ltd. | ৳ 250.00 |
| Gaviplus | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Team Pharmaceuticals Ltd. | ৳ 250.00 |
| Gavirad | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Radiant Pharmaceuticals Ltd. | ৳ 15.00 |
| Gavis | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Benham Pharmaceuticals Ltd. | ৳ 248.00 |
| Gaviscon | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Reckitt & Benckiser Ltd. | ৳ 415.00 |
| Gavisol | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Ibn Sina Pharmaceuticals Ltd. | ৳ 250.00 |
| Gavista | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Ziska Pharmaceuticals Ltd. | ৳ 250.00 |
| Gavista | 250 mg+133.5 mg+80 mg | Chewable Tablet | Ziska Pharmaceuticals Ltd. | ৳ 5.00 |
| Gavonix | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Edruc Limited | ৳ 250.00 |
| Naviscon | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Navana Pharmaceuticals Ltd. | ৳ 250.00 |
| Novelta Power | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | Orion Pharma Ltd. | ৳ 250.00 |
| Onvicon Plus | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | One Pharma Ltd. | ৳ 250.00 |
| Progavi | (500 mg+213 mg+325 mg)/10 ml | Oral Suspension | Beximco Pharmaceuticals Ltd. | ৳ 250.00 |
| Xelosil | (500 mg+213 mg+325 mg)/10 ml | Oral Suspension | Everest Pharmaceuticals Ltd. | ৳ 250.00 |
| Zeroflux | (500 mg+267 mg+160 mg)/10 ml | Oral Suspension | General Pharmaceuticals Ltd. | ৳ 250.00 |
Indication DetailsView
This preparation is indicated in Gastric reflux, Heartburn, Flatulence associated with gastric reflux, Heartburn of pregnancy, All cases of epigastric and retrosternal distress where the underlying cause is gastric reflux.
Therapeutic ClassView
Antacids
PharmacologyView
The mode of action of the product is physical and does not depend on absorption into the systemic circulation. On ingestion, the product reacts rapidly with gastric acid to form a raft of Alginic acid gel having a near-neutral pH and which floats on the stomach contents quickly and effectively impeding gastro-esophageal reflux, for up to 4 hours. In severe cases, the raft itself may be refluxed into the esophagus in preference to the stomach contents and exert a demulcent effect.
DosageView
For oral administration:
Adult and children over 12 years:10-20 mL after meals and at bedtime, up to four times a day.
Children 6 to 12 years: 5-10 mL after meals and at bedtime, up to four times a day.
Children under 6 years: Not recommended.
Elderly: No dosage modification is required for this age group.
Adult and children over 12 years:10-20 mL after meals and at bedtime, up to four times a day.
Children 6 to 12 years: 5-10 mL after meals and at bedtime, up to four times a day.
Children under 6 years: Not recommended.
Elderly: No dosage modification is required for this age group.
Side EffectsView
In addition to the desired effect of the drug, some side effects may appear such as: constipation, flatulence, stomach cramp or belching. In these cases consult a physician. If too big dose has been taken, there might appear a sensation of swelling. In this case, it is advisable to consult a physician.
ContraindicationsView
This product is contraindicated in patients with known or suspected hypersensitivity to the active ingredients or to any of the excipients.
PrecautionsView
If symptoms do not improve after 7 days, the clinical situation should be reviewed. Each 10 mL dose has a Sodium content of 141 mg (6.2 mmoL). This should be taken into account when a highly restricted salt diet is recommended, e.g. in some cases of congestive cardiac failure and renal impairment. Each 10 mL dose contains 160 mg (1.6 mmoL) of Calcium Carbonate. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi.
InteractionsView
A time-interval of 2 hours should be considered between this drug intake and the administration of other medicinal products, especially Tetracyclines, Digoxine, Fluoroquinolone, Iron salt, Ketoconazole, Neuroleptics, Thyroid Hormones, Penicillamine, beta-blockers (Atenolol, Metoprolol, Propranolol), Glucocorticoid, Chloroquine and Biphosphonates (diphosphonates) and Estramustine.
Pregnancy & LactationView
Pregnancy: Clinical studies in more than 500 pregnant women, as well as a large amount of data from post-marketing experience, indicate no malformative nor feto/neonatal toxicity of the active ingredients. This drug can be used during pregnancy, if clinically needed.
Breastfeeding: No effects of the active substances have been shown in breastfed newborns/infants of treated mothers. This drug can be used during breastfeeding.
Fertility: Pre-clinical investigations have revealed Alginate has no negative effect on parental or offspring fertility or reproduction. Clinical data do not suggest that this drug has an effect on human fertility.
Breastfeeding: No effects of the active substances have been shown in breastfed newborns/infants of treated mothers. This drug can be used during breastfeeding.
Fertility: Pre-clinical investigations have revealed Alginate has no negative effect on parental or offspring fertility or reproduction. Clinical data do not suggest that this drug has an effect on human fertility.
Overdose EffectsView
In the event of over dosage symptomatic treatment should be given. The patient may notice abdominal distension.
Storage ConditionsView
Store in a cool (below 30°C) and dry place, away from light. Keep out of the reach of children. Do not refrigerate or freeze.